Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease
Lezanne Ooi(University of Wollongong), Gerald Münch(Camden and Campbelltown Hospitals), Kuldip Sidhu(New South Wales Department of Health), Perminder S. Sachdev(UNSW Sydney), Michael D. O’Connor(Western Sydney University), Anne Poljak(UNSW Sydney), Greg T. Sutherland(Griffith University)
Cited by 51
Related Papers
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
TRPV3 is a temperature-sensitive vanilloid receptor-like protein
|Nature|2002|851
Vascular dysfunction—The disregarded partner of Alzheimer's disease
|Alzheimer s & Dementia|2019|721
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies
|Journal of Alzheimer s Disease|2015|469
Chromatin crosstalk in development and disease: lessons from REST
|Nature Reviews Genetics|2007|404